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Abstract
Background: Acute kidney injury (AKI) is commonly defined using the KDIGO system, which includes criteria based
on reduced urine output (UO). There is no consensus on whether UO should be measured using consecutive
hourly readings or mean output. This makes KDIGO UO definition and staging of AKI vulnerable to inconsistency
which has implications both for research and clinical practice. The objective of this study was to investigate
whether the way in which UO is defined affects incidence and staging of AKI.
Methods: We conducted a retrospective analysis of two single centre observational studies investigating (i) patients
undergoing cardiac surgery and (ii) patients admitted to general intensive care units (ICU). AKI was identified using
KDIGO serum creatinine (SCr) criteria and two methods of UO (UOcons: UO meeting KDIGO criteria in each
consecutive hour; UOmean: mean hourly UO meeting KDIGO criteria).
Results: Data from 151 CICU and 150 ICU admissions were analysed. Incidence of AKI using SCr alone was 23.8% in
CICU and 32% in ICU. Incidence increased in both groups when UO was considered, with inclusion of UOmean more
than doubling reported incidence of AKI (CICU: UOcons 39.7%, UOmean 72.8%; ICU: UOcons 51.3%, UOmean 69.3%). In both
groups UOcons led to a larger increase in KDIGO stage 1 but UOmean increased the incidence of KDIGO stage 2.
Conclusions: We demonstrate a serious lack of clarity in the internationally accepted AKI definition leading to
significant variability in reporting of AKI incidence.
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Background
Acute kidney injury (AKI) is a rapid deterioration of
renal function over hours to days which is associated
with adverse clinical outcomes including increased mor-
tality, prolonged length of admission, chronic kidney dis-
ease and dialysis dependence [1]. AKI is identified by
using rise in serum creatinine (SCr) and/or reduction in
urine output as surrogate markers of reduced glomerular
filtration rate. Since 2012 AKI has been commonly de-
fined and staged for severity using criteria from Kidney
Disease: Improving Global Outcomes (KDIGO) Clinical
Practice Guideline for Acute Kidney Injury [2]. The
definition proposed by KDIGO includes oliguria, which
is defined as urine volume < 0.5 ml/kg/h for 6 h.
Urine output (UO) can detect AKI earlier than SCr,
which is recognised to be a late biomarker of AKI e.g.
one study suggested that UO can detect AKI 11 h earlier
than SCr [3, 4]. In addition it is inexpensive, requiring
no laboratory input and can be measured easily by non-
specialist staff. UO has been suggested as a sensitive
marker of AKI; even very short periods of oliguria can
predict subsequent development of AKI (by KDIGO cri-
teria) and SCr rise [5]. Oliguria is also an independent
predictor of adverse clinical outcomes [6, 7].. A urine
output of < 0.3 ml/kg/h for > 6 h predicts mortality and
need for RRT in critically ill patients [5]. The KDIGO
cut off of < 0.5 ml/kg/h for > 6 h is liberal in comparison
[8]. The use of UO in addition to SCr can improve the
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ability of KDIGO criteria to predict prolonged hospital
stay, RRT or death. A recent study by Howitt et al. dem-
onstrated that patients who met both KDIGO SCr and
UO criteria for AKI stage 2 had prolonged hospital stay
and increased mid-term mortality versus those who met
only the UO criteria [9]. Patients with the same KDIGO
stage therefore had different outcomes depending on
whether AKI staging was based on SCr, UO or both [10,
11].
The value of using UO to detect AKI may be
dependent on the method used to define oliguria, as
average UO can differ according to how it is measured
and recorded [12]. In most clinical situations, particu-
larly where patients are not catheterised, UO is mea-
sured as volume of urine produced over a given period,
from which average hourly urine output can be calcu-
lated. In critical care environments UO is usually re-
corded hourly, making it possible to identify each hour
where the urine output falls below the KDIGO threshold
and whether this persists over consecutive hours.
KDIGO acknowledge that there is no consensus on
whether UO should be measured using consecutive
hourly readings or mean output over a fixed period of
time [2]. The method used can affect reported incidence
of AKI and sensitivity/specificity of UO as a diagnostic
test [12]. It is important to understand the impact that
this could have on the reliability of UO for diagnosing
AKI. Consistency in definition of UO and oliguria is im-
portant. Existing studies have been limited by focusing
on single populations and have not considered potential
variation across other clinical settings in which AKI is
common.
As a retrospective analysis of two single-centre obser-
vational studies to investigate novel urinary biomarkers,
we investigated patients admitted to cardiac intensive
care (CICU) following cardiac surgery or to a general in-
tensive care unit (ICU) to establish if differing methods
of measuring UO affected reported incidence of AKI,
stratified by stage (Stage 1–3). SCr was used as ‘gold-
standard’ for categorising AKI. We calculated sensitivity
and specificity for each method to ascertain if either
method was preferable in a given clinical setting.
Methods
We conducted a retrospective analysis of two single-
centre observational studies which had been designed
primarily to investigate the validity of putative urinary
AKI biomarkers. The two study populations were (i)
adult patients admitted to CICU following cardiac sur-
gery of any type and (ii) adult patients admitted for any
reason to general ICU in a large U.K. teaching hospital.
Patients with end stage renal disease were excluded. Eth-
ical approvals were obtained by the Nottingham AKI
Research Group as part of a wider programme of re-
search on novel urinary biomarkers for AKI.
Data collection included demographic details, reasons
for admission and clinical outcomes including mortality
and length of stay. Since all patients were catheterised,
urine output (UO) normalised to actual body weight
could be measured hourly for up to 48 h (or until death/
discharge) and SCr was recorded daily for 5 days. For pa-
tients in ICU, UO normalised to ideal body weight was
used because, for many of these patients, actual body
weight could not be measured. The proportion of pa-
tients prescribed diuretics and/or ACEi/ARBs 7 days
prior to recruitment was also recorded.
AKI was first diagnosed and staged using KDIGO SCr
criteria alone. We then staged AKI according to KDIGO
criteria using UO in addition to SCr. KDIGO definition
of AKI was an increment in SCr by ≥0.3 mg/dl [≥26.5
mol/l] within 48 h or increase in SCr to ≥1.5 times base-
line, which is known or presumed to have occurred
within the prior 7 days or urine volume < 0.5 ml/kg/h for
6 h. KDIGO stage 1 was increase in SCr by ≥0.3 mg/dl
[≥26.5 mol/l] within 48 h or increase in SCr to 1.5–1.9
times baseline or urine volume < 0.5 ml/kg/h for 6–12 h,
stage 2 was increase in SCr to 2.0–2.9 times baseline or
urine volume < 0.5 ml/kg/h for ≥12 h, stage 3 was SCr >
3.0 times baseline or initiation of renal replacement
therapy (RRT) or urine volume < 0.3 ml/kg/h for ≥24 h
or anuria for ≥12 h.
Baseline SCr was established using the methodology of
NHS England’s e-alert algorithm [13]. Baseline was de-
termined using pre-existing blood results where avail-
able. Where a result was available within 7 days prior to
ICU admission/cardiac surgery, the lowest value was
taken as baseline. Where a result existed within 365 days
but not the preceding 7 days, the median of the results
within the past 365 days was taken. Where no preceding
result existed a presumed baseline was determined by
assuming an eGFR of 75 mL/min/1.73 m2 and back-
calculating using the MDRD equation (as endorsed by
ADQI) [14, 15].
We compared two definitions of urine output. UOcons
used hourly urine output where each consecutive hour
met KDIGO criteria. The number of consecutive hours
with urine output < 0.5 mg/kg/hr., < 0.3 mg/kg/hr. or an-
uria was calculated and the highest KDIGO stage
reached using these criteria or SCr was applied. UOmean
used mean hourly urine output measured for every 6, 12
and 24 h period. The highest KDIGO stage reached
using this method or SCr was applied.
We used UOcons and UOmean to diagnose AKI using
UO alone as a binary classification test (AKI vs no-AKI)
based on KDIGO definition of AKI. We used KDIGO
SCr criteria as gold standard for diagnosis of AKI and
used 2 × 2 tables of frequencies to calculate biomarker
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characteristics (sensitivity, specificity, positive predictive
value, negative predictive value, likelihood ratio, P-value)
for each UO method in predicting AKI by SCr criteria.
In order to compare levels of agreement between two bi-
nomial variables such as an AKI event (yes/no) accord-
ing to differing criteria (SCr versus UOcons or UOmean),
levels of positive and negative agreement were calculated
according to [16, 17]. Positive agreement estimates the
conditional probability that if one of the estimates is
positive then the other estimate will also be positive.
Negative agreement assumes the converse. If both terms
are large, there is arguably less need to compare actual
to chance-predicted agreement using a kappa statistic;
more information is provided for understanding and im-
proving ratings compared with a single omnibus index.
Descriptive data of each patient cohort are presented as
mean ± 1SD for continuous variables and number of pa-
tients (% of group total) positive for each category. Stat-
istical differences between groups of patients on
admission to either cardiac surgery (CS) or intensive
care unit (ICU) were assessed by Students t-test (age
only) or chi-squared test for categorical data. To assess
the statistical significance of the predictive value of
serum creatinine or differing methods for calculating
urine output as potential markers for AKI, then logistic
regression was used (ICU only, as mortality was ex-
tremely low in CS for this cohort). Fixed binomial out-
comes such as No-AKI vs AKI were fitted with binomial
errors, with significance determined after correction for
relevant co-variates. These were determined as relevant
for inclusion in a multi-variable model if their statistical
significance in univariate analysis (i.e. fitted alone) had a
P-value of ≤0.10. The full final model reports signifi-
cance of each characteristic with associated Wald statis-
tic and F-probability, after correction for confounders
e.g. age, presence of diabetes or not and use of diuretics
or not in ICU (Referent categories, 0 were; No-Diabetes
or No-AKI or No diuretic use). Statistical significance
was accepted at P < 0.05. All data were analysed using
Genstat v19 (VSNi, Rothampsted, UK).
Results
Recruitment
Recruitment to the two studies is summarised in Fig. 1.
Patient characteristics
We analysed data from 151 patients undergoing cardiac
surgery and 150 patients admitted to ICU (Table 1). Car-
diac surgery procedures were valve surgery (45%), coron-
ary artery bypass graft (CABG; 30%), off-pump CABG
(11%), combined valve and CABG (11%), aortic root sur-
gery (2%) and other surgeries (1%). 62% were routine
procedures and 38% urgent. ICU admissions were med-
ical (34%), neurosurgical (21%), trauma (17%), elective
surgical (15%) and emergency surgical (14%). Patients
admitted for cardiac surgery in comparison to the ICU
group were older (P < .001) with a higher incidence of
CKD (P < .001) and other co-morbidities (Table 1).
Fig. 1 Summary of recruitment to the two studies of novel urinary AKI biomarkers
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Smoking was common in both groups with around half
of each group having smoked at some time. Sepsis was
significantly more common in ICU (27.3% vs 1.3% in
cardiac surgery; P < .001)).
Incidence of AKI
Incidence of AKI varied significantly according to the
definition of AKI used (Table 2). Based on SCr/RRT
alone 23.8% cardiac surgery patients developed AKI (all
stages). In ICU, 32% patients developed AKI. The
addition of UO to SCr for the diagnosis of AKI signifi-
cantly increased incidence in both groups, with the lar-
ger effect being for patients having cardiac surgery. AKI
incidence in cardiac surgery rose from 23.8% using SCr
alone to 39.8% using UOcons and to 72.9% using UOmean
(x2 = 78.8 [2df], P < .001). A similar inflation of incidence
of AKI was observed in ICU patients rising from 32 to
51.4% using UOcons and to 69.3% using UOmean (x2 =
42.8 [2df], P < .001).
Staging of AKI
When UO was used in addition to SCr/RRT to stratify
AKI by severity, the proportion of patients allocated to
each stage changed considerably for those patients ad-
mitted to cardiac surgery compared with those admitted
to ICU (Fig. 2). Using SCr alone stage 1 AKI was the
Table 1 Data are Mean ± 1SD for continuous variables and number of patients (% of group total) positive for each category
Characteristic Clinical setting P-valuea Mortality as in-patient in ICU only
CS n = 151
n (%)
ICU n = 150
n (%)
Unadjusted OR
(95% CI) P-value
Adjusted OR
(95% CI) P-value
Age, yr 68 ± 10 55 ± 17 <.001 1.04 (1.01–1.07) 0.002 1.03 (1.00–1.06) <.001
Male 110 (73) 96 (64) 0.14 1.38 (0.60–3.17) 0.44 – –
Smoking (ever) 80 (53) 63 (42) 0.057 0.62 (0.27–1.40) 0.24 – –
CKD 38 (25) 8 (5) <.001 1.19 (0.23–6.17) 0.83 – –
Diabetes 38 (25) 34 (23) 0.03 2.0 (0.87–4.79) 0.10 1.48 (0.58–3.74) 0.22
CCF 36 (24) 5 (3) <.001 2.45 (0.39–15.3) 0.33 – –
Hypertension 88 (58) 35 (23) <.001 1.31 (0.54–3.16) 0.55 – –
Sepsis 2 (1) 41 (27) <.001 0.99 (0.41–2.36) 0.99 – –
Diuretic use 60 (39) 3 (2) <.001 – – – –
AKI diagnosis based on
SCr alone 36 (24) 48 (32) 0.11 – – – –
Urine output cons 46 (31) 55 (37) 0.25 – – – –
Urine output mean 104 (69) 72 (48) <.001 – – – –
bWald, F-pr for AKI (Model 1) 66.9, 2df < .001 15.1, <.001 – – – – –
bWald, F-pr for AKI (Model 2) 67.3, 2df < .001 – – – – – –
aStatistical differences between groups of patients on admission to either cardiac surgery (CS) or intensive care unit (ICU) were assessed by Students t-test (age
only) or chi-squared test for categorical data. bAssessment of the proportion of patients diagnosed as having AKI based on differing clinical criteria (SCr, UOcons,
UOmean) were assessed by logistic regression fitting the outcome (AKI, yes/no) with a binomial error distribution. Wald statistic and F-probability are given after
correction for any significant confounders (e.g. Model 1: age & diabetes, Model 2: age, diabetes & diuretic use). Model 2 not conducted for ICU patients as so few
were on diuretics. Statistical significance was accepted at P < 0.05. SCr, serum creatinine; UO, urine output; urine output cons, output determined by volume
produced in consecutive hours; urine output mean, output determined by average volume per hour. All data analyses were conducted using Genstat v17 (VSNi,
UK). For mortality data in ICU, referent categories were coded as 0 = No-Diabetes or No-AKI
Table 2 Data are number of patients (% of group total) positive for each category. Incidence of KDIGO AKI stages 1–3 in cardiac
surgery and ICU was determined using SCr alone vs two methods of measuring urine output (UO). KDIGO stage 1 was increase in
SCr by ≥0.3 mg/dl [≥26.5 mol/l] within 48 h or increase in SCr to 1.5–1.9 times baseline or urine volume < 0.5 ml/kg/h for 6–12 h,
stage 2 was increase in SCr to 2.0–2.9 times baseline or urine volume < 0.5 ml/kg/h for ≥12 h, stage 3 was SCr > 3.0 times baseline
or initiation of renal replacement therapy or urine volume < 0.3 ml/kg/h for ≥24 h or anuria for ≥12 h. UOcons required urine volume
to meet KDIGO criteria for each consecutive hour over any 6, 12 or 24 h period. UOmean was mean urine volume meeting KDIGO
criteria over any 6, 12 or 24 h period
SCr/RRT alone UOcons + SCr UOmean + SCr
Cardiac Surgery (n = 151) ICU (n = 150) Cardiac Surgery (n = 151) ICU (n = 150) Cardiac Surgery (n = 151) ICU (n = 150)
Stage 1 24 (15.9) 22 (14.6) 46 (30.5) 42 (28) 47 (31.1) 29 (19.3)
Stage 2 3 (1.98) 11 (7.3) 5 (3.3) 19 (12.7) 54 (35.8) 55 (36.7)
Stage 3 9 (6) 15 (10) 9 (6) 16 (10.7) 9 (6) 20 (13.3)
All AKI 36 (23.8) 48 (32) 60 (39.7) 77 (51.3) 110 (72.8) 104 (69.3)
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most common category in both clinical settings (15.9%
in cardiac surgery vs 14.6% in ICU). Incidence of stage 1
AKI doubled in both groups when UO was added to the
diagnostic criteria using UOcons. In cardiac surgery there
was no difference between incidence of stage 1 AKI be-
tween UOcons and UO mean (Fig. 2). In ICU incidence of
AKI stage 1 was reduced using UOmean (UOmean 19.3%
versus UOcons 28%). Incidence of stage 2 AKI was low in
both groups using SCr (1.9% in cardiac surgery, 7.3% in
ICU) but rose modestly when UOcons was applied (3.3%
in cardiac surgery, 12.7% in ICU). Using UOmean inci-
dence of stage 2 AKI was dramatically inflated, with an
increase of 33.8% in cardiac surgery and 29.4% in ICU
(Fig. 1). There was no difference in incidence of stage 3
AKI in cardiac surgery when either method of UO meas-
urement was used, with a small rise in stage 3 AKI
(2.6%) when UO mean was used in ICU.
Sensitivity and specificity of urine output
A comparison between UOcons and UOmean versus SCr/
RRT as gold standard for diagnosis of AKI revealed sig-
nificant differences between the two methods (Table 3).
UOcons had reasonable specificity in both groups (79% in
cardiac surgery and 73% in ICU respectively) and was
therefore good at identifying patients without subse-
quent SCr rise. UOmean had poor specificity in both
groups (36% in cardiac surgery and 45% in ICU respect-
ively) due to a high false positive rate. In cardiac surgery,
sensitivity of using UOmean to diagnose AKI was high at
83% with most patients who developed AKI by SCr cri-
teria being correctly identified by UO. In ICU, sensitivity
was relatively low at 67%.
Urine output as a predictor of outcomes
The ability of UO to predict clinical outcomes was
assessed by logistic regression in the ICU group alone,
due to higher mortality in this group compared with car-
diac surgery. In ICU, 11/150 patients died within 72 h,
33/150 patients had died within 30 days and 39/150 had
died within 1 year. In cardiac surgery, 0/150 died within
72 h, 5/150 patients had died within 30 days, with no
further increase in mortality at 1 year. In univariate
models, age was found to be a significant predictor of
mortality with presence of diabetes also having a weak
confounding effect (P = 0.10). Age and diabetes status
were thus retained in a multivariate model to assess the
predictive ability of UO for mortality (Table 1). For both
unadjusted and fully adjusted models, SCr alone was the
only significant predictor of mortality for patients admit-
ted to ICU (Table 1).
Discussion
Using SCr alone, incidence of AKI in cardiac surgery (all
stages) of 23.8% was consistent with published studies. A
recent meta-analysis covering the period from 2004 to
2014 showed similar incidence of 22.3% (13.6% stage 1,
3.8% stage 2, and 2.7% stage 3) with 2.3% patients re-
quiring RRT [18]. Incidence of AKI in ICU using SCr
was lower than published data would predict. The AKI-
EPI study looked at multi-national data to estimate inci-
dence of AKI, reporting an incidence of just under 60%
in critically ill patients [1]. Incidence of AKI in our ICU
population was just 32%. This might be explained by our
ICU cohort including 21% neurosurgical patients, as this
Fig. 2 Incidence of KDIGO AKI stages 1–3 in cardiac surgery and ICU was determined using SCr alone vs two methods of measuring urine
output. KDIGO stage 1 was increase in SCr by ≥0.3 mg/dl [≥26.5 mol/l] within 48 h or increase in SCr to 1.5–1.9 times baseline or urine volume <
0.5 ml/kg/h for 6–12 h, stage 2 was increase in SCr to 2.0–2.9 times baseline or urine volume < 0.5 ml/kg/h for ≥12 h, stage 3 was SCr > 3.0 times
baseline or initiation of renal replacement therapy or urine volume < 0.3 ml/kg/h for ≥24 h or anuria for ≥12 h. UOcons required urine volume to
meet KDIGO criteria for each consecutive hour over any 6, 12 or 24 h period. UOmean was mean urine volume meeting KDIGO criteria over any 6,
12 or 24 h period
Allen et al. BMC Nephrology           (2020) 21:19 Page 5 of 8
subgroup is known to have relatively low incidence of
AKI compared with general adult ICU patients.
When UO was included in the diagnostic criteria for
AKI, incidence rose in both groups. The larger effect
was seen in cardiac surgery. There was a significant dif-
ference depending on which method of UO measure-
ment was used. UOcons led to a small increase in AKI in
both groups. Despite the increase in incidence of AKI
using UOcons, there was only modest variation from pub-
lished incidence in cardiac surgery; in ICU incidence
rose to a level comparable with published data. When
UOmean was applied, AKI incidence in cardiac surgery
rose steeply; overall incidence exceeded 70% which is
significantly higher than in most published studies. This
finding is consistent with results reported by Koeze et al.
who found that use of UO together with SCr may in-
crease incidence of AKI by up to 50% [4]. This suggests
that UOmean significantly overestimates incidence of AKI
in cardiac surgery. A similar inflation of AKI incidence
is also present, albeit to a smaller degree, in the ICU
group when UO criteria are additionally considered
alongside SCr. Taken together, these data suggest that
using mean urine output is likely to lead to an over diag-
nosis of AKI post-cardiac surgery. Although this patient
group has been extensively studied with respect to AKI,
few studies have included UO criteria for defining and
staging AKI. This might explain the absence of this find-
ing in the literature and highlights the importance of
using specific and consistent UO criteria.
The impact of using UO was particularly evident when
AKI diagnosis was stratified by AKI stage. Both UOcons
and UOmean led to an increase in incidence of KDIGO
stage 1, but UOcons had little impact on incidence of
KDIGO stage 2–3 AKI in either group. Increased inci-
dence of KDIGO stage 1 has less impact clinically be-
cause it is associated with fewer and less severe adverse
outcomes and is sometimes excluded from large clinical
studies of AKI such as TRIBE-AKI [19]. UOmean in-
creased incidence of KDIGO stage 2 AKI in both groups,
with the larger effect again being in the cardiac surgery
group. This appears to lead to an over diagnosis of
KDIGO stage 2 AKI. In ICU this correlated with reduc-
tion in the number of people diagnosed with KDIGO
stage 1 AKI. This suggests that, as well as leading to over
diagnosis of AKI, UOmean may also lead to misclassifica-
tion as KDIGO stage 2. Furthermore, since urine output
is an outcome measure corrected to body weight, then
accurate measurement of body weight, rather than an es-
timation of ‘ideal’ body weight, can also inflate AKI inci-
dence in certain clinical settings such as ICU [20].
Potential consequences of this could include inappropri-
ate initiation of RRT and misclassification in clinical
studies of AKI. It is important that this risk is recog-
nised, as mean UO is the only way of measuring UO in
the majority of medical patients who do not have a urin-
ary catheter in situ and on wards where UO may be
measured less frequently than hourly.
Our results demonstrate that either UO method used
independently from serum creatinine was poor at identi-
fying AKI. This is consistent with data from the TRIBE-
AKI meta-analysis which found the AUROC for post-
operative UO as a marker for AKI was just 0.59 [19].
The use of UO independently from SCr is also inferior
at predicting outcomes of length of stay, need for RRT
and mortality [9]. Whilst UOcons is less likely than
UOmean to over-estimate AKI incidence, the sensitivity is
impacted by clinical factors influencing UO such as fluid
boluses or diuretics. Patients who are truly oliguric may
have a temporary increase in UO which means they no
longer meet the consecutive hourly criteria. Absence of
oliguria does not itself exclude AKI, as non-oliguric AKI
(e.g. contrast induced AKI) is common [12].
The increased sensitivity and high false positive rate of
using mean UO may also be influenced by clinical fac-
tors such as urinary obstruction or inadequate fluid re-
suscitation which can affect UO irrespective of renal
function or injury. This observation was also made by
Ralib et al., who criticised KDIGO UO criteria as being
too liberal [8]. In order to reflect glomerular filtration
the patient must be adequately hydrated before UO can
Table 3 Sensitivity, specificity, positive predictive value and negative predictive value (95% CI) were calculated using 2 × 2 tables of
frequencies. KDIGO SCr criteria were applied (Increase in SCr by ≥0.3 mg/dl[≥26.5 mol/l] within 48 h or increase in SCr to ≥1.5 times
baseline (which is known or presumed to have occurred within the prior 7 days)) as gold standard for diagnosing AKI. AKI by urine
output was defined using KDIGO criteria as urine volume < 0.5 ml/kg/h for 6 h. UOcons required urine volume < 0.5 ml/kg/h each
consecutive hour for ≥6 h. UOmean was mean urine volume < 0.5 ml/kg/h over any > 6 h period
UOcons UOmean
Cardiac Surgery (n = 151) ICU (n = 150) Cardiac Surgery (n = 151) ICU (n = 50)
Number patients with AKI 46 (30.5) 55 (36.7) 104 (68.9) 72 (48)
Sensitivity 0.61 (0.45–0.77) 0.58 (0.44–0.72) 0.83 (0.71–0.95) 0.67 (0.53–0.80)
Specificity 0.79 (0.71–0.86) 0.73 (0.63–0.81) 0.36 (0.26–0.44) 0.45 (0.35–0.54)
PPV 0.48 (0.33–0.62) 0.50 (0.36–0.63) 0.29 (0.20–0.37) 0.36 (0.26–0.46)
NPV 0.87 (0.80–0.93) 0.79 (0.70–0.86) 0.87 (0.77–0.96) 0.74 (0.63–0.85)
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be useful. The AKIN classification addressed this point
but in practice it is difficult to determine “adequate” hy-
dration [21]. Changes in UO can be physiological and
not represent disease but rather an auto regulatory re-
sponse [22]. A study by Solomon in a UK intensive care
unit demonstrated that 22% junior doctors had physio-
logical oliguria and were more likely to be oliguric than
their patients [23].
The different effects in cardiac surgery and ICU of the
two methods of measuring UO suggest that UO is af-
fected by clinical variables in different patient groups. It
is important that this is recognised particularly in view
of the fact that mean UO is commonly used in most
medical settings due to practicalities of patient manage-
ment (avoiding unnecessary urinary catheterisation),
clinical staffing and cost constraints. To our knowledge
no previous study has compared the use of UO in ICU
with patients undergoing cardiac surgery in order to
diagnose AKI.
Limitations of this study included its retrospective de-
sign (as part of an observational study investigating novel
AKI biomarkers) and the fact that it was conducted in a
single centre, although two separate clinical cohorts were
studied. Use of SCr as gold standard for AKI definition is
a well-documented limitation of most studies of AKI inci-
dence, as SCr is accepted to be a late and poor marker of
AKI. In addition, diuretic use was relatively high in the
setting of cardiac surgery. Dose and frequency of diuretic
administration may confound analyses involving urine
output. We have not compared our results with markers
of tubular injury or function as ‘biomarkers of AKI’ be-
cause these have been validated only in certain clinical set-
tings and are not yet in routine use.
Conclusions
Our study demonstrates that reported incidence of AKI
differs according to the method used to document UO
and that the extent of this effect varies between different
clinical groups. Clarification of method of UO calcula-
tion is important in both clinical and research settings.
This single-centre study provides justification for con-
ducting a larger multi-centre study in order to establish
more specific criteria for AKI definition.
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